The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Molecular Stratification of Clear Cell Renal Cell Carcinoma by Consensus Clustering Reveals Distinct Subtypes and Survival Patterns
Open accessAbstract
Clear cell renal cell carcinoma (ccRCC) is the predominant RCC subtype, but even within this classification, the natural history is heterogeneous and difficult to predict. A sophisticated understanding of the molecular features most discriminatory for the underlying tumor heterogeneity should be predicated on identifiable and biologically meaningful patterns of gene expression. Gene expression microarray data were analyzed using software that implements iterative unsupervised consensus clustering algorithms to identify the optimal molecular subclasses, without clinical or other classifying information. ConsensusCluster analysis identified two distinct subtypes of ccRCC within the training set, designated clear cell type A (ccA) and B (ccB). Based on the core tumors, or most well-defined arrays, in each subtype, logical analysis of data (LAD) defined a small, highly predictive gene set that could then be used to classify additional tumors individually. The subclasses were corroborated in a validation data set of 177 tumors and analyzed for clinical outcome. Based on individual tumor assignment, tumors designated ccA have markedly improved disease-specific survival compared to ccB (median survival of 8.6 vs 2.0 years, P = 0.002). Analyzed by both univariate and multivariate analysis, the classification schema was independently associated with survival. Using patterns of gene expression based on a defined gene set, ccRCC was classified into two robust subclasses based on inherent molecular features that ultimately correspond to marked differences in clinical outcome. This classification schema thus provides a molecular stratification applicable to individual tumors that has implications to influence treatment decisions, define biological mechanisms involved in ccRCC tumor progression, and direct future drug discovery.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Molecular portraits of human breast tumours
Perou, C. M., Sørlie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., Rees, C. A., Pollack, J. R., Ross, D. T., Johnsen, H., Akslen, L. A., et al. (2000) · Nature · doi:10.1038/35021093 · Cited by 16,261
Kohonen, T. (2001) · Springer Series in Information Sciences · doi:10.1007/978-3-642-56927-2 · Cited by 16,019
Jolliffe, I. (2005) · Encyclopedia of Statistics in Behavioral Science · doi:10.1002/0470013192.bsa501 · Cited by 14,310
Sørlie, T., Perou, C. M., Tibshirani, R., Aas, T., Geisler, S., Johnsen, H., Hastie, T., Eisen, M. B., van de Rijn, M., Jeffrey, S. S., et al. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.191367098 · Cited by 10,938
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
van de Vijver, M. J., He, Y. D., van 't Veer, L. J., Dai, H., Hart, A. A. M., Voskuil, D. W., Schreiber, G. J., Peterse, J. L., Roberts, C., Marton, M. J., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa021967 · Cited by 6,488
A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer
Paik, S., Shak, S., Tang, G., Kim, C., Baker, J., Cronin, M., Baehner, F. L., Walker, M. G., Watson, D., Park, T., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041588 · Cited by 6,277
Monti, S., Tamayo, P., Mesirov, J., & Golub, T. (2003) · Machine Learning · doi:10.1023/a:1023949509487 · Cited by 2,116
Applied Multivariate Data Analysis
Jobson, J. D. (1992) · Springer Texts in Statistics · doi:10.1007/978-1-4612-0921-8 · Cited by 1,825
Silencing of the VHL tumor-suppressor gene by DNA methylation in renal carcinoma.
Herman, J. G., Latif, F., Weng, Y., Lerman, M. I., Zbar, B., Liu, S., Samid, D., Duan, D. S., Gnarra, J. R., & Linehan, W. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9700 · Cited by 1,529
Singular Value Decomposition and Principal Component Analysis
Wall, M. E., Rechtsteiner, A., & Rocha, L. M. (2005) · A Practical Approach to Microarray Data Analysis · doi:10.1007/0-306-47815-3_5 · Cited by 1,215
FRANK, I., BLUTE, M. L., CHEVILLE, J. C., LOHSE, C. M., WEAVER, A. L., & ZINCKE, H. (2002) · Journal of Urology · doi:10.1016/s0022-5347(05)64153-5 · Cited by 1,175
Improved Prognostication of Renal Cell Carcinoma Using an Integrated Staging System
Zisman, A., Pantuck, A. J., Dorey, F., Said, J. W., Shvarts, O., Quintana, D., Gitlitz, B. J., deKernion, J. B., Figlin, R. A., & Belldegrun, A. S. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1649 · Cited by 729
Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors
Nickerson, M. L., Jaeger, E., Shi, Y., Durocher, J. A., Mahurkar, S., Zaridze, D., Matveev, V., Janout, V., Kollarova, H., Bencko, V., et al. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-4921 · Cited by 588
A Practical Approach to Microarray Data Analysis
(2003) · Kluwer Academic Publishers eBooks · doi:10.1007/b101875 · Cited by 528
SORBELLINI, M., KATTAN, M. W., SNYDER, M. E., REUTER, V., MOTZER, R., GOETZL, M., McKIERNAN, J., & RUSSO, P. (2005) · Journal of Urology · doi:10.1097/01.ju.0000148261.19532.2c · Cited by 528
HIF-α effects on c-Myc distinguish two subtypes of sporadic VHL-deficient clear cell renal carcinoma
Gordan, J. D., Lal, P., Dondeti, V. R., Letrero, R., Parekh, K. N., Oquendo, C. E., Greenberg, R. A., Flaherty, K. T., Rathmell, W. K., Keith, B., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.016 · Cited by 493
Self-citationImproved detection of germline mutations in the von Hippel-Lindau disease tumor suppressor gene
Stolle, C., Glenn, G., Zbar, B., Humphrey, J. S., Choyke, P., Walther, M., Pack, S., Hurley, K., Andrey, C., Klausner, R., et al. (1998) · Human Mutation · doi:10.1002/(sici)1098-1004(1998)12:6<417::aid-humu8>3.0.co;2-k · Cited by 479
Takahashi, M., Rhodes, D. R., Furge, K. A., Kanayama, H.-O., Kagawa, S., Haab, B. B., & Teh, B. T. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.171209998 · Cited by 403
Banks, R. E., Tirukonda, P., Taylor, C., Hornigold, N., Astuti, D., Cohen, D., Maher, E. R., Stanley, A. J., Harnden, P., Joyce, A., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-3074 · Cited by 275
Cause-effect relationships and partially defined Boolean functions
Crama, Y., Hammer, P. L., & Ibaraki, T. (1988) · Annals of Operations Research · doi:10.1007/bf02283750 · Cited by 242
Gene Expression Profiling Predicts Survival in Conventional Renal Cell Carcinoma
Zhao, H., Ljungberg, B., Grankvist, K., Rasmuson, T., Tibshirani, R., & Brooks, J. D. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0030013 · Cited by 231
Self-citationAlexe, G., Dalgin, G. S., Scanfeld, D., Tamayo, P., Mesirov, J. P., DeLisi, C., Harris, L., Barnard, N., Martel, M., Levine, A. J., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0539 · Cited by 207
Self-citationConsensusCluster: A Software Tool for Unsupervised Cluster Discovery in Numerical Data
Seiler, M., Huang, C., Szalma, S., & Bhanot, G. (2010) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2009.0083 · Cited by 123
Self-citationLogical analysis of data—An overview: From combinatorial optimization to medical applications
Hammer, P. L., & Bonates, T. O. (2006) · Annals of Operations Research · doi:10.1007/s10479-006-0075-y · Cited by 121
Furge, K. A., Lucas, K. A., Takahashi, M., Sugimura, J., Kort, E. J., Kanayama, H.-O., Kagawa, S., Hoekstra, P., Curry, J., Yang, X. J., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-0534 · Cited by 107
Portraits of breast cancer progression
Dalgin, G. S., Alexe, G., Scanfeld, D., Tamayo, P., Mesirov, J. P., Ganesan, S., DeLisi, C., & Bhanot, G. (2007) · BMC Bioinformatics · doi:10.1186/1471-2105-8-291 · Cited by 48
Self-citationDifferential gene expression identifies subgroups of renal cell carcinoma
Skubitz, K. M., Zimmerman, W., Kammerer, R., Pambuccian, S. E., & Skubitz, A. P. N. (2006) · Journal of Laboratory and Clinical Medicine · doi:10.1016/j.lab.2006.04.001 · Cited by 46
Molecular markers for predicting prognosis of renal cell carcinoma
Nogueira, M. A., & Kim, H. L. (2007) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2007.03.028 · Cited by 45
Renal Epithelial Neoplasms: Diagnostic Applications of Gene Expression Profiling
Young, A. N., Master, V. A., Paner, G. P., Wang, M. D., & Amin, M. B. (2008) · Advances in Anatomic Pathology · doi:10.1097/pap.0b013e3181594720 · Cited by 24
Cited by
Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing
Gerlinger, M., Rowan, A. J., Horswell, S., Larkin, J., Endesfelder, D., Gronroos, E., Martinez, P., Matthews, N., Stewart, A., Tarpey, P., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1113205 · Cited by 7,774
Comprehensive molecular characterization of clear cell renal cell carcinoma
The Cancer Genome Atlas Research Network (2013) · Nature · doi:10.1038/nature12222 · Cited by 3,485
Integrated molecular analysis of clear-cell renal cell carcinoma
Sato, Y., Yoshizato, T., Shiraishi, Y., Maekawa, S., Okuno, Y., Kamura, T., Shimamura, T., Sato-Otsubo, A., Nagae, G., Suzuki, H., et al. (2013) · Nature Genetics · doi:10.1038/ng.2699 · Cited by 1,221
Şenbabaoğlu, Y., Gejman, R. S., Winer, A. G., Liu, M., Van Allen, E. M., de Velasco, G., Miao, D., Ostrovnaya, I., Drill, E., Luna, A., et al. (2016) · Genome Biology · doi:10.1186/s13059-016-1092-z · Cited by 968
Clear cell renal cell carcinoma ontogeny and mechanisms of lethality
Jonasch, E., Walker, C. L., & Rathmell, W. K. (2021) · Nature Reviews Nephrology · doi:10.1038/s41581-020-00359-2 · Cited by 644
Self-citation
Metadata
- Authors
- Brannon, A. R., Reddy, A., Seiler, M., Arreola, A., Moore, D. T., Pruthi, R. S., Wallen, E. M., Nielsen, M. E., Liu, H., Nathanson, K. L., Ljungberg, B., Zhao, H., Brooks, J. D., Ganesan, S., Bhanot, G., & Rathmell, W. K.
- Venue
- Genes & Cancer
- Publisher
- SAGE Publications
- Published
- 2010-02-01
- Volume
- 1
- Issue
- 2
- Pages
- 152-163
- ISSN
- 1947-6019 (ISSN-L)
- 1947-6027
- OpenAlex
- W2110320497
- Cited by
- 331
- References
- 29
- FWCI
- 13.77
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.